Bioventus (BVS) Competitors

National Vision (NASDAQ:EYE) and Bioventus (NYSE:BVS) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

Which has more risk and volatility, EYE or BVS?

National Vision has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500.

Which has preferable earnings & valuation, EYE or BVS?

National Vision has higher revenue and earnings than Bioventus.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.82B	1.01	-$28.50M	-$0.18	-129.00
Bioventus	$564.14M	1.10	-$156.23M	N/A	N/A

Is EYE or BVS more profitable?

National Vision has a net margin of -0.75% compared to Bioventus' net margin of -7.11%. Bioventus' return on equity of 15.61% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	-0.75%	3.56%	1.49%
Bioventus	-7.11%	15.61%	4.01%

Do analysts recommend EYE or BVS?

National Vision presently has a consensus target price of $24.73, indicating a potential upside of 6.49%. Bioventus has a consensus target price of $13.75, indicating a potential upside of 82.60%. Given Bioventus' stronger consensus rating and higher possible upside, analysts plainly believe Bioventus is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Bioventus	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Does the media prefer EYE or BVS?

In the previous week, National Vision had 1 more articles in the media than Bioventus. MarketBeat recorded 12 mentions for National Vision and 11 mentions for Bioventus. National Vision's average media sentiment score of 1.01 beat Bioventus' score of 0.28 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	3 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bioventus	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals & insiders believe in EYE or BVS?

62.9% of Bioventus shares are owned by institutional investors. 2.7% of National Vision shares are owned by insiders. Comparatively, 33.0% of Bioventus shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Bioventus beats National Vision on 8 of the 15 factors compared between the two stocks.